To evaluate the impact of OIP5‐AS1 on obesity‐induced alteration of myocardial structure in vivo, we examined the effect of inhibition of OIP5‐AS1 on HFD‐induced myocardial hypertrophy, fibrosis, and remodeling. The gene discussed is OIP5; the disease is obesity disorder.